Reasons for Refusal of Newborn Vitamin K Prophylaxis: Implications for Management and Education

Harvey James Hamrick1, Elizabeth Kaye Gable2, Emily Hruska Freeman1

  • 1Department of Pediatrics and.

Hospital Pediatrics
|December 30, 2015
PubMed

Insights

Many parents refuse vitamin K prophylaxis for newborns due to concerns about ingredients and dosage, often influenced by internet information. Prenatal education addressing these specific parental concerns is crucial for improving vitamin K uptake.

Area of Science:

  • Pediatrics
  • Neonatal Health
  • Public Health

Background:

  • The American Academy of Pediatrics strongly recommends intramuscular (IM) vitamin K prophylaxis for all newborns.
  • Vitamin K deficiency bleeding (VKDB) in newborns, especially late-onset VKDB, can have severe consequences.
  • Understanding parental refusal of this vital prophylaxis is essential for improving infant health outcomes.

Purpose of the Study:

  • To investigate the factors influencing parents' decisions to refuse IM vitamin K prophylaxis for their newborns.
  • To identify the primary concerns and information sources utilized by parents who decline this intervention.

Main Methods:

  • A survey was administered to parents intending to refuse IM vitamin K prophylaxis at delivery across various birth settings in a Southeastern state.
  • The survey collected data on demographics, parenting choices, and specific concerns regarding vitamin K, including information sources and perceived risks.

Main Results:

  • The incidence of refusal was highest in birthing centers.
  • Parents refusing vitamin K often also refused other standard newborn interventions like the hepatitis B vaccine and erythromycin eye ointment.
  • Common concerns cited were synthetic ingredients, excessive dosage, and potential side effects, with the Internet being the primary information source (70%).

Conclusions:

  • Parents refusing IM vitamin K prophylaxis often base their decisions on information found online, focusing on perceived risks related to ingredients and dosage.
  • Prenatal education is critical and must proactively address parental concerns identified through online resources to improve acceptance rates of vitamin K prophylaxis.
Abstract

Related Concept Videos

Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
3.0K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
372
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
702
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
461